Skip to main content
NOVAVAX INC logo

NOVAVAX INC — Investor Relations & Filings

Ticker · NVAX ISIN · US6700024010 LEI · 529900J4GJHPEPQ23205 US Manufacturing
Open in API
Filings indexed 1,095 across all filing types
Latest filing 2014-08-13 Regulatory Filings
Country US United States of America
Listing US NVAX

About NOVAVAX INC

https://www.novavax.com/?locale=US

Novavax Inc. is a biotechnology company that develops and commercializes vaccines to prevent serious infectious diseases. The company utilizes a proprietary, protein-based vaccine technology platform, which includes its novel Matrix-M™ adjuvant, to create its vaccine candidates. Its primary commercial product is a protein-based COVID-19 vaccine, Nuvaxovid™. Novavax's research and development pipeline is focused on addressing significant health needs, including influenza and a combination COVID-19-influenza vaccine. The company's strategy emphasizes advancing its pipeline assets and establishing strategic partnerships to maximize the global health impact of its technology.

Recent filings

Filing Released Lang Actions
FORM S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock incentive plans. It includes details about the number of shares registered, the plan under which they are issued, and signatures of company officers. This is a regulatory filing related to securities registration, not a financial report, earnings release, or management discussion. It does not contain financial statements or analysis but is a formal registration statement for securities issuance. Therefore, it fits best under Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a report publication notice but a full registration statement filing.
2014-08-13 English
10-Q
Interim / Quarterly Report Q2 2014
2014-08-07 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 6, 2014, reporting the company's financial results for the quarter ended June 30, 2014. It includes a press release as an exhibit announcing the quarterly financial results. The text explicitly states that the press release is attached as Exhibit 99.1 and is a summary announcement of financial results, not the full detailed financial statements or comprehensive analysis. The document length is 3349 characters, which is relatively short and consistent with an earnings release announcement rather than a full interim or quarterly report. Therefore, this document is best classified as an Earnings Release (ER).
2014-08-07 English
FORM 4 SUBMISSION
Director's Dealing
2014-08-04 English
FORM 4 SUBMISSION
Director's Dealing
2014-08-04 English
FORM 4 SUBMISSION
Director's Dealing
2014-08-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.